Is quantitation of whole blood Epstein-Barr virus DNA useful for assessing treatment response in patients with non-Hodgkin 's lymphoma?
These results suggest that whole blood EBV-DNA quantitation might be of value as a convenient biomarker for therapeutic responsiveness of NHL.
These findings suggest that microbial metabolites of PHGG and GG, and possibly SCFAs, reduce intestinal barrier defects and inflammation in colitic mice.